Chackerian Alissa A, Oldham Elizabeth R, Murphy Erin E, Schmitz Jochen, Pflanz Stefan, Kastelein Robert A
Discovery Research, Schering-Plough Biopharma (formerly DNAX Research), Palo Alto, CA 94304, USA.
J Immunol. 2007 Aug 15;179(4):2551-5. doi: 10.4049/jimmunol.179.4.2551.
IL-33 (IL-1F11) is a recently described member of the IL-1 family of cytokines that stimulates the generation of cells, cytokines, and Igs characteristic of a type 2 immune response. IL-33 mediates signal transduction through ST2, a receptor expressed on Th2 and mast cells. In this study, we demonstrate that IL-33 and ST2 form a complex with IL-1R accessory protein (IL-1RAcP), a signaling receptor subunit that is also a member of the IL-1R complex. Additionally, IL-1RAcP is required for IL-33-induced in vivo effects, and IL-33-mediated signal transduction can be inhibited by dominant-negative IL-1RAcP. The implications of this shared usage of IL-1RAcP by IL-1(alpha and beta) and IL-33 are discussed.
白细胞介素-33(IL-1F11)是白细胞介素-1细胞因子家族中最近被描述的成员,它能刺激2型免疫反应所特有的细胞、细胞因子和免疫球蛋白的生成。IL-33通过ST2介导信号转导,ST2是在Th2细胞和肥大细胞上表达的一种受体。在本研究中,我们证明IL-33和ST2与白细胞介素-1受体辅助蛋白(IL-1RAcP)形成复合物,IL-1RAcP是一种信号受体亚基,也是IL-1受体复合物的成员。此外,IL-1RAcP是IL-33诱导的体内效应所必需的,并且IL-33介导的信号转导可被显性负性IL-1RAcP抑制。本文讨论了IL-1(α和β)和IL-33共同使用IL-1RAcP的意义。